A New Target for Painkillers: Snail Toxins Show the Way
A brand new approach to treating severe nerve pain – by aiming drugs at a previously unrecognized molecular target – has been discovered by University of Utah scientists who study the venoms of deadly, sea-dwelling cone snails.
(Embargoed until 13-Nov-2006, 17:00 ET)
PNAS, 13-Nov-2006
—University of Utah Diet and Exercise Both Work to Cut Risk of Diabetes
Exercise and diet work equally well in reducing the risk factors for diabetes, a new study finds. (Embargo expired on 08-Nov-2006 at 00:00 ET)
Am. J. of Clinical Nutrition, Nov-2006
—Saint Louis University Medical Center New Guideline for the Diagnostic Assessment of Children with Continuous Seizures
A new guideline developed by the American Academy of Neurology and the Child Neurology Society aims to help physicians diagnose the causes of status epilepticus, a state of continuous seizures, in children, many of whom have epilepsy. The guideline is published in the November 14, 2006, issue of Neurology, the scientific journal of the American Academy of Neurology. (Embargoed until 13-Nov-2006, 16:00 ET)
Neurology, 14-Nov-2006
—American Academy of Neurology (AAN) Counseling for Spouses Keeps Alzheimer’s Patients Out of Nursing Homes
Spouses of Alzheimer’s disease patients are less likely to put their loved ones in a nursing home if they receive enhanced caregiver support and counseling. Researchers say their findings could potentially save millions of dollars in nursing home care costs, according to a study published in the November 14, 2006, issue of Neurology, the scientific journal of the American Academy of Neurology. (Embargoed until 13-Nov-2006, 16:00 ET)
Neurology, 14-Nov-2006
—American Academy of Neurology (AAN) Allergy and Immunology on the Cusp of Major Breakthroughs
Allergy and immunology is on the threshold of major therapeutic discoveries based on a 40-year history of increasing our fundamental understanding of how the immune system works according to research presented at the allergists’ annual meeting. (Embargoed until 09-Nov-2006, 06:00 ET)
ACAAI Annual Meeting
—American College of Allergy, Asthma and Immunology (ACAAI) Complementary Medicine Has a Role in the Treatment of Allergic Diseases
Complementary or alternative medicine (CAM) has increased tremendously in popularity in the United States, and one of the most common reasons that patients turn to CAM is for treating allergic diseases according to information presented at the allergists’ annual meeting. Experts study the role of CAM treatments including traditional Chinese medicine and probiotics. (Embargoed until 11-Nov-2006, 06:00 ET)
ACAAI Annual Meeting
—American College of Allergy, Asthma and Immunology (ACAAI) Experts Say Many Allergic Skin Disorders Are Treatable
Allergic skin disorders, such as urticaria and atopic dermatitis, can cause much discomfort, have an impact on quality of life, and can sometimes cause serious complications for adults and children. Experts present information on how these disorders can often be effectively treated during the allergists’ annual meeting. (Embargoed until 11-Nov-2006, 06:00 ET)
ACAAI Annual Meeting
—American College of Allergy, Asthma and Immunology (ACAAI) Allergists Explore Rising Prevalence and Unmet Needs Attributed to Allergic Rhinitis
As the prevalence of allergic rhinitis appears to be rising, there are increasing concerns about its impact on health, sleep, work and school performance, as well as unmet patient needs regarding its treatment according to information presented at the allergists’ annual meeting. (Embargoed until 12-Nov-2006, 06:00 ET)
ACAAI Annual Meeting
—American College of Allergy, Asthma and Immunology (ACAAI) Women Who Are “Allergic” to Their Husbands and Other Gender-Related Research
Women who have vaginal itching, burning and other symptoms after intercourse may be allergic to their partner’s semen – yet, for some, having more frequent sex can be part of the treatment. Women also may react to other allergic substances transmitted in seminal fluid according to information presented at the allergists’ annual meeting. (Embargoed until 13-Nov-2006, 06:00 ET)
ACAAI Annual Meeting
—American College of Allergy, Asthma and Immunology (ACAAI) Antibody Reduces Rejection in High-risk Kidney Transplants
To prevent rejection, nearly 70 percent of kidney transplant patients get short-term drug therapy during surgery. In the first direct comparison of the two drugs most commonly given to block acute rejection, a study led by Washington University School of Medicine in St. Louis shows that one - anti-thymocyte globulin - is superior. (Embargoed until 08-Nov-2006, 17:00 ET)
NEJM, 9-Nov-2006
—Washington University in St. Louis Research Findings on Anaphylaxis and Food, Insect Allergy Unveiled
Preliminary research on the diagnosis and treatment of allergic diseases presented at the allergists’ annual meeting includes key investigations on anaphylaxis, food allergy and insect reactions. (Embargoed until 12-Nov-2006, 06:00 ET)
ACAAI Annual Meeting
—American College of Allergy, Asthma and Immunology (ACAAI) Research Findings on Allergic Asthma Unveiled
Preliminary research on the diagnosis and treatment of allergic diseases presented at the allergists’ annual meeting includes key investigations on allergic asthma. (Embargoed until 12-Nov-2006, 06:00 ET)
—American College of Allergy, Asthma and Immunology (ACAAI) Research Findings in Allergy-Immunology Unveiled
Preliminary research on the diagnosis and treatment of allergic diseases presented at the allergists’ annual meeting includes key investigations on allergic rhinitis, non-allergic conjunctivitis, immunotherapy, metal allergy, semen allergy and skin disorders. (Embargoed until 12-Nov-2006, 06:00 ET)
ACAAI Annual Meeting
—American College of Allergy, Asthma and Immunology (ACAAI) Researchers Develop Novel Method for Treatment of Sickle Cell Disease
Virginia Commonwealth University researchers have developed a unique anti-sickling agent that may one day be effective in treating sickle cell disease, a painful and debilitating genetic blood disorder that affects approximately 80,000 Americans.
—Virginia Commonwealth University Gene Linked with Mental Illness Shapes Brain Region
A gene variant associated with mental illness goes hand-in-hand with enlargement of a brain region that handles negative emotions, researchers at UT Southwestern Medical Center and the Central Texas Veterans Health Care System have found.
Biological Psychiatry, Nov-2006
—UT Southwestern Medical Center ATS Publishes New Statement on Hepatotoxicity of Antituberculosis Therapy
The American Thoracic Society (ATS) has published a new statement on the pathogenesis, prevention and treatment of liver damage caused by anti-tuberculosis (TB) medications.
Am. J. of Respiratory and Critical Care Medicine, 15-Oct-2006
—American Thoracic Society (ATS) Antioxidants: New Kid on the Block for Pain Relief?
Antioxidant-based pain killers may one day become a viable alternative to addictive medications such as morphine. Researchers found that synthetic antioxidants practically eradicated pain-like behavior in nearly three-quarters of mice with inflamed hind paws.
Behavioural Brain Research
—Ohio State University The Skinny on Post-baritaric Plastic Surgery
For the 170,000 morbidly obese patients who undergo bariatric surgery each year in the U.S., the stomach-reducing procedure is just the first step back to health and self-esteem.
—NewYork-Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College Study Evaluates Two Medications for ADHD
University of Illinois at Chicago researchers are comparing two drugs commonly used to treat attention deficit hyperactivity disorder (ADHD) to determine if genetic factors predict which children will respond to either or both drugs.
—University of Illinois at Chicago Eating Disorders Organization Calls on Insurers to Cover Treatment
The Academy for Eating Disorders has drafted the Worldwide Charter for Action on Eating Disorders, an international bill of rights for people with eating disorders and their families, that calls for insurance companies and health care systems around the world to provide coverage for the treatment of people with eating disorders that is equal to the treatment available to those with any major medical illness.
—Sherwood Group 1st Cancer Vaccine of the 21st century, An Insider Perspective
The Mount Sinai will honor Douglas Lowy, Laboratory Chief and Principal Investigator, Laboratory of Cellular Oncology, Division of Basic Sciences, National Cancer Institute, NIH and John Schiller, Deputy Chief and Principal Investigator, Laboratory of Cellular Oncology, Division of Basic Sciences, National Cancer Institute, NIH, for research contributions which led to the clinical development of the Human Papillomavirus (HPV) vaccine against cervical cancer.
1st Cancer Vaccine of the 21st century, An Insider Perspective from the NIH
—Mount Sinai Medical Center Professor Earns Prestigious Medical Award for Leishmaniasis Work
Army Col. (Dr.) Naomi Aronson, an assistant professor of medicine and class of 1981 alumna of the Uniformed Services University of the Health Sciences (USU), was named the recipient of the 2007 Richard and Hinda Rosenthal Foundation First Award by the American College of Physicians (ACP).
—Uniformed Services University of the Health Sciences (USU) Neurology Names New Editor-in-Chief
The American Academy of Neurology has named a new editor-in-chief of its scientific journal Neurology, the world’s leading clinical neurology journal. John H. Noseworthy, MD, FAAN, with the Mayo Clinic College of Medicine in Rochester, Minnesota, will succeed Editor-in-Chief Robert C. Griggs, MD, FAAN. Griggs completes his 10-year term December 31, 2006.
—American Academy of Neurology (AAN) Editor-in-Chief of Neurology Ends 10-Year Term
The editor-in-chief of Neurology, the scientific journal of the American Academy of Neurology and the leading clinical neurology journal worldwide, is ending his 10-year term. Robert C. Griggs, MD, FAAN, will complete his term as editor-in-chief December 31, 2006.
—American Academy of Neurology (AAN) New Scientist Press Release - Issue 11 November 2006
1)Report on home-schooling in the US 2)Global warming as a human rights issue 3) Uterus transplants 4)Neanderthal genome 5)Food fraud 6)Decline of autopsies. (Embargoed until 08-Nov-2006, 14:00 ET)
—New Scientist An Old Discovery Could Boost Ethanol Production from Plant Fiber
A discovery some 40 years ago is showing promise as a chemical pre-treatment that breaks down plant fiber. That could release the simple sugars in corn stalks or switchgrass so they can be fermented into ethanol. And that could add value to Iowa's crops or the fibrous co-products of ethanol production.
—Iowa State University Brain Injury May Occur within One Millisecond After Head Hits Car Windshield
Research by a Sandia engineer and a University of New Mexico Health Sciences Center neurologist shows that brain injury may occur within one millisecond after a human head is thrust into a windshield in a car accident. This happens before any overall motion of the head following impact with the windshield and is a new concept to consider for doctors interested in traumatic brain injury.
—Sandia National Laboratories Setting the Record Straight: Human Embryonic Stem Cell Research
William M. Caldwell, IV, Chief Executive Officer of Advanced Cell Technology, Inc. today issued this statement to the media and the investment community.
—Advanced Cell Technology Meeting: Composite Nanodevices in Imaging & Nano Radiation Therapy
Principles and mechanisms of nanotechnology will be examined by Mohamed K. Khan, MD, PhD, NanoBiotechnology Center, Roswell Park Cancer Institute (RPCI) during the 48th annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), November 5-9 in Philadelphia, PA.
American Society for Therapeutic Radiology and Oncology
—Roswell Park Cancer Institute Society of Environmental Toxicology and Chemistry North America Announces Award Winners
The Society of Environmental Toxicology and Chemistry North America announces 7 awards given by the society at the annual meeting in Montreal.
—Society of Environmental Toxicology and Chemistry (SETAC) Business, Industry, Government Preview Energy Research
The Nov. 29-30 Energy Research Engagement Showcase at Virginia Tech will foster commercialization of research from Virginia universities in the energy and energy-related environmental fields, enhance public-private partnerships, stimulate economic development, and facilitate the adoption of profitable energy solutions. The showcase is part of Virginia Tech’s “Energy Ideas” initiative, a year-long series of events.
Energy Research Engagement Showcase
—Virginia Tech (Virginia Polytechnic Institute and State University) Today's Turkey - A Modern Miracle
Americans love their turkey. In fact, they love it so much, consumption has grown 106 percent since 1970. And although we usually think of turkey as a holiday staple, the fact is Americans eat it year-round. But the turkey of today is not the wild turkey of yesterday. University of Maryland Associate Professor Nickolas Zimmermann explains.
—University of Maryland, College Park Fulbright Reports Spelman College a Top Producer of Fulbright Fellows for 2006-2007
Spelman is listed as one of the "top-producing" campuses in Carnegie's classification that had the highest number of students who received Fulbright grants this year.
—Spelman College Water: More Valuable than Diamonds
A new study by University of Arkansas economists shows a strong relationship between economic freedom and access to water. Researchers compared data from two important international indices and found that greater economic freedom leads to economic development, which in turn decreases the amount of poverty associated with a nation’s lack of access to water.
Forum of the Association for Arid Lands Studies
—University of Arkansas, Fayetteville Job Seekers Use Both Print and Online Advertising
Seventy percent of all job seekers reported using newspapers and online ads to look for employment, The Conference Board reported today.
—Conference Board Jury Finds in Favor of Mass. Eye and Ear Infirmary in Visudyne Case
The Massachusetts Eye and Ear Infirmary (MEEI) announces that yesterday, in the United States District Court for the District of Massachusetts, a jury found in favor of MEEI on claims of unjust enrichment and unfair trade practices against QLT Inc.
—Massachusetts Eye and Ear Infirmary |